BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korfei M, Mahavadi P, Guenther A. Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option. Cells 2022;11:1626. [DOI: 10.3390/cells11101626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ligresti G, Raslan AA, Hong J, Caporarello N, Confalonieri M, Huang SK. Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis. Gene 2023;859:147142. [PMID: 36603696 DOI: 10.1016/j.gene.2022.147142] [Reference Citation Analysis]
2 Pellegrino M, Ricci E, Ceraldi R, Nigro A, Bonofiglio D, Lanzino M, Morelli C. From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer. Cancers (Basel) 2022;14:4401. [PMID: 36139561 DOI: 10.3390/cancers14184401] [Reference Citation Analysis]
3 Fontana A, Cursaro I, Carullo G, Gemma S, Butini S, Campiani G. A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors. Int J Mol Sci 2022;23:10014. [PMID: 36077415 DOI: 10.3390/ijms231710014] [Reference Citation Analysis]
4 El Agha E, Wygrecka M. State of the Art in Idiopathic Pulmonary Fibrosis. Cells 2022;11:2487. [DOI: 10.3390/cells11162487] [Reference Citation Analysis]